PA-19-053 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
| Title |
Notice Number |
Organization |
Release
Date |
Expiration
Date |
Activity
Code(s) |
Expired NOSIs
| Title |
Notice Number |
Organization |
Release
Date |
Expiration
Date |
Activity
Code(s) |
| Notice of Special Interest: NCCIH High Priority Pain Research |
NOT-AT-22-007 |
NCCIH
|
Dec 20, 2021 |
Dec 15, 2022
|
R01, R21, R15, R34 |
| Notice of Special Interest (NOSI): Advancing Research on SUD through Computational Neuroscience |
NOT-DA-20-022 |
NIDA
|
May 5, 2020 |
Sep 8, 2023
|
R01, R21 |
| Notice of Special Interest (NOSI): Data Driven Research on Coronavirus Disease 2019 (COVID-19) (R21) |
NOT-LM-20-011 |
NLM
|
Apr 27, 2020 |
Jun 17, 2020
|
R21 |
| Notice of Special Interest (NOSI): Cannabis, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults |
NOT-DA-20-014 |
NIDA
|
Apr 22, 2020 |
Sep 8, 2023
|
R01, R03, R21 |
| Notice of Special Interest: Promoting Research on Mechanisms of Pathogenesis and Pathophysiology of Atypical Femoral Fracture (AFF) and Osteonecrosis of the Jaw (ONJ) |
NOT-AR-21-006 |
NIAMS ORWH NIDCR NIA
|
Apr 15, 2020 |
Jul 18, 2023
|
R01, R21 |
| Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions |
NOT-CA-20-044 |
NCI
|
Apr 9, 2020 |
May 8, 2023
|
R03, R21, R01, P01 |
| Notice of Special Interest (NOSI): Neuroimmune Signaling and Function in Substance Use Disorders |
NOT-DA-20-046 |
NIDA
|
Apr 7, 2020 |
Sep 8, 2023
|
R01, R21, R15, 333 |
| RESCINDED - Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) |
NOT-AI-20-031 |
NIAID
|
Mar 27, 2020 |
Apr 5, 2021
|
R03, R21, 333, R01, R43/R44, R41/R42 |
| Notice of Special Interest (NOSI): Exploring the Roles of Biomolecular Condensates (BMCs) in
Substance Use Disorder and/or HIV-related processes |
NOT-DA-20-018 |
NIDA
|
Mar 25, 2020 |
Sep 8, 2023
|
R01, R03, R21, 333 |
| Notice of Special Interest (NOSI):Sleep and Substance Use Disorders |
NOT-DA-20-021 |
NIDA
|
Mar 25, 2020 |
Sep 8, 2023
|
R01, R03, R21, K99/R00, R61/R33 |
| Notice of Special Interest (NOSI): Research to Improve the Interpretation of Patient-Reported Outcomes at the Individual Patient Level for Use in Clinical Practice |
NOT-OD-20-079 |
OBSSR ODP NIAAA NINDS NINR NHGRI NIDCD NIAMS NCCIH NCI NIMH NIMHD ORWH NIA
|
Mar 24, 2020 |
Jan 8, 2022
|
R21, R01 |
| Notice of Special Interest (NOSI): Competitive Revisions for Firearms Injury and Mortality Prevention Research |
NOT-OD-20-089 |
OBSSR NIA NICHD NIMH NCCIH ODP NIMHD ORWH NIAAA
|
Mar 20, 2020 |
May 16, 2020
|
R01, R21 |
| Notice of Special Interest: Alcohol and Cancer Control |
NOT-CA-20-034 |
NCI
|
Mar 19, 2020 |
Sep 9, 2023
|
R01, R21, R03, 333 |
| Notice of Special Interest (NOSI): Advancing Head and Neck Cancer Early Detection Research (AHEAD) |
NOT-CA-20-031 |
NCI NIDCR
|
Mar 10, 2020 |
Jan 8, 2022
|
R03, R21, R01 |
| Notice of Special Interest (NOSI): Effects of Cannabis Use and Cannabinoids on the Developing Brain |
NOT-DA-20-039 |
NIDA
|
Mar 5, 2020 |
Sep 8, 2023
|
R01, R03, R21 |
| Notice of Special Interest (NOSI): Mechanistic Investigations of Psychosocial Factors Associated with Substance Use Disorders |
NOT-DA-20-005 |
NIDA
|
Mar 3, 2020 |
Sep 8, 2023
|
R01, R21 |
| Notice of Special Interest (NOSI): Going Global: Using Gene Network Analyses to Understand the Etiology of SUD |
NOT-DA-20-020 |
NIDA
|
Feb 26, 2020 |
Sep 8, 2023
|
R01, R03, R21, 333 |
| Notice of Special Interest (NOSI): Research on Oral Anticancer Agents in the Contexts of Utilization, Adherence, and Health Care Delivery |
NOT-CA-20-026 |
NCI
|
Feb 21, 2020 |
May 8, 2023
|
R01, R21, R03, P01 |
| Notice of Special Interest (NOSI): Drug-drug interactions among substances of abuse, medications to treat HIV infection, and pharmacotherapies to treat substance use disorders |
NOT-DA-20-013 |
NIDA
|
Feb 6, 2020 |
May 8, 2022
|
R01, R03, R21 |
| Notice of Special Interest (NOSI): Transcriptomic, epigenomic, regulatory RNA or functional genomic research in Substance Use Disorders |
NOT-DA-20-031 |
NIDA
|
Feb 6, 2020 |
Jan 8, 2023
|
R01, R03, R21, 333, R21/R33 |
| Notice of Special Interest (NOSI): Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers |
NOT-CA-20-022 |
NCI
|
Jan 15, 2020 |
Jan 8, 2023
|
R01, R21, R03 |
| Notice of Special Interest: Development of Statistical, Population Genetics and Computational Methods Related to Polygenic Prediction of Health and Disease in Diverse Populations |
NOT-HG-20-010 |
NHGRI NCI NHLBI
|
Jan 13, 2020 |
Oct 5, 2023
|
R01, R21, R03 |
| Notice of Special Interest (NOSI): Preclinical and Clinical Studies of the Interactions of Opioids and Stimulants |
NOT-DA-20-007 |
NIDA
|
Jan 6, 2020 |
Jun 5, 2023
|
R03, R21, R01 |
| Notice of Special Interest (NOSI): Modeling Social Contagion of Substance Use Epidemics |
NOT-DA-20-009 |
NIDA
|
Jan 2, 2020 |
Jan 8, 2023
|
R01, R03, R21 |
| Notice of Special Interest (NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics |
NOT-AI-20-013 |
NIAID NIBIB
|
Dec 17, 2019 |
Jan 8, 2023
|
R43/R44, R41/R42, R21, R01 |
| Notice of Special Interest: Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes |
NOT-AT-20-002 |
NCCIH
|
Dec 13, 2019 |
Jan 8, 2022
|
R01, R21 |
| Notice of Special Interest: Promoting research opportunities on HIV/AIDS in NIAMS |
NOT-AR-20-005 |
NIAMS
|
Oct 22, 2019 |
Jan 10, 2023
|
R01, R21, 333 |
| Notice of Special Interest: High-Priority Research Topics for PA-19-053 and PA-19-056 |
NOT-AG-19-037 |
NIA NIAMS
|
Sep 4, 2019 |
Jan 8, 2022
|
R21, R01 |
| Notice of Special Interest (NOSI) of NIDCD and NEI in Supporting Research on Usher Syndrome |
NOT-DC-19-007 |
NIDCD NEI
|
Sep 4, 2019 |
Jan 8, 2022
|
U01, R01, R21, R24, P50, UG1 |
| Notice of Special Interest (NOSI): Epidemiology of Drug Abuse |
NOT-DA-19-066 |
NIDA
|
Aug 29, 2019 |
Jan 8, 2022
|
R01, R21, R03, 333 |
| Notice of Special Interest (NOSI): Public Health Research on Cannabis |
NOT-DA-19-065 |
NIDA
|
Aug 14, 2019 |
Jan 8, 2022
|
R01, R21, R03, 333 |
| Notice of Special Interest (NOSI): The Application of Big Data Analytics to Drug Abuse Research |
NOT-DA-19-041 |
NIDA
|
Jul 12, 2019 |
Jan 8, 2022
|
R01, R21, R03 |
| Notice of Special Interest (NOSI): Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R01, R21, R03) |
NOT-DA-19-037 |
NIDA
|
Jul 11, 2019 |
Sep 8, 2022
|
R01, R21, R03 |
| Notice of Special Interest (NOSI): Research to Prevent Drug Use, Misuse and Addiction |
NOT-DA-19-048 |
NIDA
|
Jul 10, 2019 |
Jan 8, 2022
|
R01, R21, R03 |
| Notice of Special Interest (NOSI): Gene-Environment Interplay in Substance Use Disorders (R01, R21) |
NOT-DA-19-038 |
NIDA
|
Jul 10, 2019 |
Jan 8, 2022
|
R01, R21 |
| Notice of Special Interest (NOSI): Bold New Bioengineering Research for Heart, Lung, Blood and Sleep Disorders and Diseases |
NOT-HL-19-678 |
NHLBI
|
Mar 14, 2019 |
Jan 8, 2022
|
R21 |
| Notice of Availability of Competitive Supplements/Revisions for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project (Competitive Supplement/Revision Clinical Trial Optional) |
NOT-OD-19-071 |
NIH
|
Feb 5, 2019 |
Mar 17, 2019
|
R01, R03, R21, U01 |
|
NIH Grants and Funding
Warning! This browser is not supported - Some features might not work. Try using a different browser such as Chrome, Edge, Firefox, or Safari.
NIH Staff 
